MX2009006893A - Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales. - Google Patents
Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales.Info
- Publication number
- MX2009006893A MX2009006893A MX2009006893A MX2009006893A MX2009006893A MX 2009006893 A MX2009006893 A MX 2009006893A MX 2009006893 A MX2009006893 A MX 2009006893A MX 2009006893 A MX2009006893 A MX 2009006893A MX 2009006893 A MX2009006893 A MX 2009006893A
- Authority
- MX
- Mexico
- Prior art keywords
- cattle
- animals
- pharmaceutical compositions
- treating inflammation
- disclosed
- Prior art date
Links
- 241000283690 Bos taurus Species 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- NOOCSNJCXJYGPE-UHFFFAOYSA-N flunixin Chemical compound C1=CC=C(C(F)(F)F)C(C)=C1NC1=NC=CC=C1C(O)=O NOOCSNJCXJYGPE-UHFFFAOYSA-N 0.000 abstract 1
- 229960000588 flunixin Drugs 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87090706P | 2006-12-20 | 2006-12-20 | |
| PCT/US2007/025808 WO2008082507A2 (en) | 2006-12-20 | 2007-12-18 | Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006893A true MX2009006893A (es) | 2009-07-03 |
Family
ID=39262615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006893A MX2009006893A (es) | 2006-12-20 | 2007-12-18 | Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9006272B2 (enExample) |
| EP (1) | EP2120860B1 (enExample) |
| JP (1) | JP5377326B2 (enExample) |
| KR (1) | KR20090091328A (enExample) |
| CN (2) | CN101588789B (enExample) |
| AR (1) | AR064425A1 (enExample) |
| AU (1) | AU2007339312B2 (enExample) |
| BR (1) | BRPI0720500B1 (enExample) |
| CA (1) | CA2672964C (enExample) |
| CL (1) | CL2007003711A1 (enExample) |
| CO (1) | CO6190598A2 (enExample) |
| ES (1) | ES2714550T3 (enExample) |
| MX (1) | MX2009006893A (enExample) |
| NZ (1) | NZ598554A (enExample) |
| PE (1) | PE20081406A1 (enExample) |
| RU (1) | RU2466715C2 (enExample) |
| TW (1) | TWI350182B (enExample) |
| WO (1) | WO2008082507A2 (enExample) |
| ZA (1) | ZA200904329B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2738970A1 (en) * | 2008-10-31 | 2010-05-06 | Moberg Derma Ab | Topical composition comprising a combination of at least two penetration enhancing agents |
| CA2828086C (en) | 2010-03-10 | 2018-07-31 | Nuvo Research Inc. | Foamable formulation |
| WO2012022837A1 (en) * | 2010-08-16 | 2012-02-23 | Helsingin Yliopisto | Transdermal compositions |
| WO2012043701A1 (ja) * | 2010-09-30 | 2012-04-05 | 富山化学工業株式会社 | 経皮吸収製剤 |
| CN114903848A (zh) * | 2013-02-27 | 2022-08-16 | 阿根塔创新有限公司 | 透皮制剂 |
| CN105769827B (zh) * | 2016-03-09 | 2018-07-17 | 金陵科技学院 | 用于动物清热镇痛氟尼辛葡甲胺涂膜剂及其制备方法 |
| KR20200065711A (ko) | 2018-11-30 | 2020-06-09 | 한원경 | 동물 피부질환 개선용 조성물 |
| WO2021010843A1 (en) | 2019-07-16 | 2021-01-21 | Donaghys Limited | Transdermal solvent system and methods of use |
| WO2021045870A1 (en) * | 2019-09-06 | 2021-03-11 | Iowa State University Research Foundation, Inc. | Mirtazapine as a pre-shipping inhibitor of bovine respiratory disease |
| JP7846689B2 (ja) * | 2020-11-25 | 2026-04-15 | インターベット インターナショナル ベー． フェー． | フルニキシンを口腔投与することによる疼痛の治療方法 |
| WO2022238965A1 (en) * | 2021-05-12 | 2022-11-17 | Argenta Innovation Limited | Veterinary transdermal formulation |
| CN114404360B (zh) * | 2021-12-16 | 2023-03-28 | 江西益昕葆生物科技有限公司 | 一种氟尼辛葡甲胺注射液的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63225316A (ja) * | 1986-10-21 | 1988-09-20 | Nitto Electric Ind Co Ltd | 外皮投与用組成物 |
| JPH11222443A (ja) * | 1997-11-11 | 1999-08-17 | Saitama Daiichi Seiyaku Kk | 経皮吸収促進組成物および経皮吸収製剤 |
| AU1780101A (en) | 1999-11-19 | 2001-05-30 | Xel Herbaceuticals | Transdermal delivery system for alkaloids of aconitum species |
| JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
| US6790867B2 (en) * | 2002-05-20 | 2004-09-14 | Schering-Plough Animal Health Corporation | Compositions and method for treating infection in cattle and swine |
| CA2530407A1 (en) * | 2003-07-23 | 2005-02-03 | The Regents Of The University Of California | Penetration enhancer combinations for transdermal delivery |
| JP2007500691A (ja) | 2003-07-31 | 2007-01-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗炎症剤の分散性製剤 |
| DE10358525A1 (de) * | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
| US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| CA2573412A1 (en) * | 2004-07-19 | 2006-02-02 | Warner-Lambert Company Llc | Formulation for stimulating hair growth |
| AU2005284422A1 (en) * | 2004-09-16 | 2006-03-23 | Bayer Healthcare Ag | Dermally applicable formulations for treating skin diseases in animals |
| WO2007061739A2 (en) * | 2005-11-21 | 2007-05-31 | Schering-Plough Ltd. | Pharmaceutical compositions comprising buprenorphine |
-
2007
- 2007-12-14 PE PE2007001807A patent/PE20081406A1/es not_active Application Discontinuation
- 2007-12-18 RU RU2009127500/15A patent/RU2466715C2/ru active
- 2007-12-18 KR KR1020097014552A patent/KR20090091328A/ko not_active Ceased
- 2007-12-18 MX MX2009006893A patent/MX2009006893A/es active IP Right Grant
- 2007-12-18 NZ NZ59855407A patent/NZ598554A/xx unknown
- 2007-12-18 EP EP07867799.4A patent/EP2120860B1/en active Active
- 2007-12-18 AR ARP070105702 patent/AR064425A1/es not_active Application Discontinuation
- 2007-12-18 WO PCT/US2007/025808 patent/WO2008082507A2/en not_active Ceased
- 2007-12-18 CN CN2007800470359A patent/CN101588789B/zh active Active
- 2007-12-18 JP JP2009542867A patent/JP5377326B2/ja active Active
- 2007-12-18 AU AU2007339312A patent/AU2007339312B2/en active Active
- 2007-12-18 US US11/959,185 patent/US9006272B2/en active Active
- 2007-12-18 ES ES07867799T patent/ES2714550T3/es active Active
- 2007-12-18 CN CN201310549264.8A patent/CN103690471B/zh active Active
- 2007-12-18 BR BRPI0720500A patent/BRPI0720500B1/pt active IP Right Grant
- 2007-12-18 CA CA2672964A patent/CA2672964C/en active Active
- 2007-12-19 TW TW096148778A patent/TWI350182B/zh not_active IP Right Cessation
- 2007-12-19 CL CL2007003711A patent/CL2007003711A1/es unknown
-
2009
- 2009-06-17 CO CO09062884A patent/CO6190598A2/es not_active Application Discontinuation
- 2009-06-19 ZA ZA200904329A patent/ZA200904329B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200833367A (en) | 2008-08-16 |
| AU2007339312A1 (en) | 2008-07-10 |
| CA2672964A1 (en) | 2008-07-10 |
| RU2009127500A (ru) | 2011-01-27 |
| CA2672964C (en) | 2018-04-03 |
| KR20090091328A (ko) | 2009-08-27 |
| CL2007003711A1 (es) | 2008-07-25 |
| CO6190598A2 (es) | 2010-08-19 |
| RU2466715C2 (ru) | 2012-11-20 |
| CN103690471B (zh) | 2015-11-18 |
| NZ598554A (en) | 2013-08-30 |
| EP2120860A2 (en) | 2009-11-25 |
| WO2008082507A3 (en) | 2009-03-19 |
| US20080153885A1 (en) | 2008-06-26 |
| TWI350182B (en) | 2011-10-11 |
| JP2010513500A (ja) | 2010-04-30 |
| BRPI0720500A8 (pt) | 2015-12-29 |
| ZA200904329B (en) | 2010-05-26 |
| ES2714550T3 (es) | 2019-05-29 |
| BRPI0720500B1 (pt) | 2019-01-02 |
| CN103690471A (zh) | 2014-04-02 |
| US9006272B2 (en) | 2015-04-14 |
| AU2007339312B2 (en) | 2013-06-06 |
| WO2008082507A2 (en) | 2008-07-10 |
| JP5377326B2 (ja) | 2013-12-25 |
| CN101588789A (zh) | 2009-11-25 |
| AR064425A1 (es) | 2009-04-01 |
| BRPI0720500A2 (pt) | 2014-02-04 |
| CN101588789B (zh) | 2013-12-11 |
| PE20081406A1 (es) | 2008-10-17 |
| EP2120860B1 (en) | 2019-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200833367A (en) | Pharmaceutical compositions and method for treating inflammation in cattle and other animals | |
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| BRPI0922789A2 (pt) | peptídeo de ligação de albumina intermediador para reconhecimento de doença | |
| UA81629C2 (ru) | Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней | |
| ZA200810125B (en) | Pharmaceutical combination comprising 3- (3-dimethy-lamin0-1-ethyl-2-methyl-pr0pyl)-phenol and an NSAID | |
| EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| MX2009001711A (es) | Formulaciones de liberacion sostenida de topiramato. | |
| NO20076508L (no) | Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav | |
| BR112015006828A2 (pt) | composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar uma doença em um paciente em necessidade do tratamento; e método para modular a atividade de uma proteína ire1 | |
| BRPI0810336A2 (pt) | "método para tratar e/ou prevenir úlceras de pele em um indivíduo" | |
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| DK2012764T3 (da) | Farmaceutisk kombination omfattende 3-(3-dimethylamino-1-ethyl-2methyl-propyl)-phenol og paracetamol | |
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| BRPI0715609A2 (pt) | Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica | |
| JP2017531042A (ja) | ピラゾリン由来化合物ならびに哺乳動物における変形性関節疾患に由来する炎症および疼痛に対する週間投与計画におけるその使用 | |
| IN2009CN03512A (enExample) | ||
| NO20075508L (no) | Stannsoporfinpreparater og administrering | |
| TW200600094A (en) | Pharmaceutical compositions for prevention or treatment of disorders of lipid metabolism | |
| WO2007067753A3 (en) | Methods of reducing side effects in cancer therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| GB | Transfer or rights |
Owner name: INTERVET INTERNATIONAL B.V. |
|
| FG | Grant or registration |